Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis.

Esmeralda CastelblancoPierre GourdyRiccardo C BonadonnaNick FreemantleGregory BigotCeline MauquoiAlice CioccaMireille BonnemaireDirk Müller-Wieland

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)

Although an eGFR of 15-44 mL/min/1.73 m2 was associated with a slightly increased risk of hypoglycaemia among patients with inadequately controlled T2DM, Gla-300 provided glycaemic improvement with an overall favourable safety profile regardless of baseline eGFR.

Keyphrases

type diabetes
data analysis
glycemic control
small cell lung cancer
chronic kidney disease
epidermal growth factor receptor
tyrosine kinase
end stage renal disease
insulin resistance
randomized controlled trial
double blind